摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-(1-hydroxycarbonylethyl)-oxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one | 99007-87-1

中文名称
——
中文别名
——
英文名称
7-(1-hydroxycarbonylethyl)-oxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one
英文别名
7-(1-Carboxyethoxy)-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one;2-((3-(4-Hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl)oxy)propanoic acid;2-[3-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxypropanoic acid
7-(1-hydroxycarbonylethyl)-oxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one化学式
CAS
99007-87-1
化学式
C18H14O6
mdl
——
分子量
326.306
InChiKey
VVOLYJNOTQWXLG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    575.7±50.0 °C(Predicted)
  • 密度:
    1.420±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    24
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    93.1
  • 氢给体数:
    2
  • 氢受体数:
    6

SDS

SDS:fbe2d07e1af75d15430faa8f838cbc3f
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    参考文献:
    名称:
    Synthesis of Potential Antidipsotropic Isoflavones:  Inhibitors of the Mitochondrial Monoamine Oxidase−Aldehyde Dehydrogenase Pathway
    摘要:
    Recently we have shown that daidzin, the major active principle of an ancient herbal treatment for "alcohol addiction", suppresses ethanol intake in alcohol-preferring laboratory animals. Further, we have identified the monoamine oxidase (MAO)-aldehyde dehydrogenase (ALDH-2) pathway of the mitochondria as the potential site of action of daidzin. Daidzin analogues that potently inhibit ALDH-2 but have no or little effect on MAO are most antidipsotropic, whereas those that also inhibit MAO exhibit little, if any, antidipsotropic activity. Therefore, in the design and synthesis of more potent antidipsotropic analogues, structural features important for the inhibition of both ALDH-2 and MAO must be taken into consideration. To gain further information on the structure-activity relationships at the inhibitor binding sites of ALDH-2 and MAO, we prepared 44 analogues of daidzin and determined their potencies for ALDH-2 and MAO inhibition. Results indicate that a sufficient set of criteria for a potent antidipsotropic analogue is an isoflavone with a free 4 ' -OH function and a straight-chain alkyl substituent at the 7 position that has a terminal polar function such as -OH, -COOH, or -NH2. The preferable chain lengths for the 7-O-omega -hydroxy, 7-O-omega -carboxy, and 7-O-omega -amino subsitutents are 2 less than or equal to n less than or equal to 6, 5 less than or equal to 5 n less than or equal to 10, and n greater than or equal to 4, respectively. Analogues that meet these criteria have increased potency for ALDH-2 inhibition and/or decreased potency for MAO inhibition and therefore are likely to be potent antidipsotropic agents.
    DOI:
    10.1021/jm0101390
点击查看最新优质反应信息

文献信息

  • Treatment for osteoporosis
    申请人:Takeda Chemical Industries, Ltd.
    公开号:US04644012A1
    公开(公告)日:1987-02-17
    A compound of the formula ##STR1## wherein R.sup.1 is hydrogen or hydroxy, R.sup.2 and R.sup.3 are independently hydrogen or lower alkyl and Y is carboxyl or a group convertible to carboxyl is effective for prevention or treatment of osteoporosis.
    式为##STR1##的化合物,其中R.sup.1是氢或羟基,R.sup.2和R.sup.3分别是氢或较低的烷基,而Y是羧基或可转化为羧基的基团,对于预防或治疗骨质疏松症是有效的。
  • Ground mixture
    申请人:Takeda Chemical Industries, Ltd.
    公开号:EP0129893A2
    公开(公告)日:1985-01-02
    A ground mixture of a poorly soluble cystalline drug and an adsorbent is remarkably improved in the rates of dissolution and absorption of the drug.
    将溶解性较差的胱氨酸药物和吸附剂混合研磨后,可显著提高药物的溶解和吸收率。
  • Method for treating osteoporosis
    申请人:Takeda Chemical Industries, Ltd.
    公开号:EP0146921A2
    公开(公告)日:1985-07-03
    A compound of the formula wherein R1 is hydrogen or hydroxy, R2 and R3 are independently hydrogen or lower alkyl and Y is carboxyl or a group convertible to carboxyl is effective for prevention or treatment of osteoporosis.
    式中的化合物 其中 R1 为氢或羟基,R2 和 R3 独立地为氢或低级烷基,Y 为羧基或可转化为羧基的基团,可有效预防或治疗骨质疏松症。
  • Benzopyran-4-on derivatives and their production
    申请人:Takeda Chemical Industries, Ltd.
    公开号:EP0146922A2
    公开(公告)日:1985-07-03
    Novel benzopyran-4-on derivatives of the formula wherein R1 is hydrogen or hydroxy and R2 is lower alkyl and production theirof.
    式中 R1 为氢或羟基,R2 为低级烷基的新型苯并吡喃-4-on 衍生物及其制备方法。 其中 R1 为氢或羟基,R2 为低级烷基及其衍生物。
  • ——
    作者:TSUDA MASAO、 SAWA YOICHI、 YAMAZAKI IWAO
    DOI:——
    日期:——
查看更多